John Podtetenieff handles patent prosecution and contentious matters on behalf of biotechnology, pharmaceutical, and chemistry sector clients.
John has experience in the full spectrum of patent proceedings before the European Patent Office — including drafting, prosecution, opposition, and appeal — as well as national infringement and invalidity proceedings. He has assisted diverse clients ranging from small start-ups in need of basic IP advice to multinational pharmaceutical companies requiring advice on their freedom-to-operate and litigation matters.
Prior to practicing intellectual property law, John was a research scientist working in the fields of metagenomic drug discovery, biocatalysis, directed evolution, and protein engineering, with particular emphasis on developing efficient green catalysts yielding enantiomerically pure molecules. He is a member of the Chartered Institute of Patent Attorneys and the European Patent Institute.
- Queen Mary University of London (Postgraduate Certificate in Intellectual Property Law 2012; M.Sc. in Management of Intellectual Property 2012); University of Edinburgh (Ph.D. in Chemistry 2006); University of California, San Diego (B.S. in Biochemistry and Cell Biology 2000)
- European Patent Office (EPO)
- English, French